Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
Type:
Grant
Filed:
June 11, 2014
Date of Patent:
September 27, 2016
Assignees:
BIONURE FARMA, S.L., INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PII SUNYER (IDIBAPS) (undivided 30% interest), CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (individed 20% interest)